The neo-adjuvant treatment in gastrointestinal stromal tumor

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 8, 2010, Pages 727-730

  Catania, Vito ^a   Consoli, A ^a   Cavallaro, A ^a   Liardo, R L E ^a   Malaguarnera, M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

GIST; Imatinib mesylate; Neo adjuvant treatment

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GASTRECTOMY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; MALE; MOTOR DYSFUNCTION; MUSCLE CRAMP; POSITRON EMISSION TOMOGRAPHY; TUMOR VASCULARIZATION; TUMOR VOLUME; ADJUVANT THERAPY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

AGED; COMBINED MODALITY THERAPY; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; NEOADJUVANT THERAPY; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 77955934410     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. PIDHORECKY I, CHENEY RT, KRAYBILL WG, GIBBS JF. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000; 7: 705-712.
2. BLAY JY, LANDI B, BONVALOT S, MONGES G, RAY-COQUARD I, DUFFAUD F, BUI NB, BUGAT R, CHAYVIALLE JA, ROUGIER P, BOUCHÉ O, BONICHON F, LASSAU N, VANEL D, NORDLINGER B, STOECKLE E, MEEUS P, COINDRE JM, SCOAZEC JY, EMILE JF, RANCHÈRE D, LE CESNE A. Recommendations for the management of GIST patients. Bull Cancer 2005; 92: 907-918.
3. KINDBLOM LG, REMOTTI HE, ALDENBORG F, MEIS-KINDBLOM JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152: 1259-1269.
4. TAZAWA K, TSUKADA, K, MAKUUCHI H, TSUTSUMI Y. An immunohistochemical and clinicopathological study of gastrointestinal stromal tumors. Pathol Int 1999; 49: 786-798. (Pubitemid 29513293)
5. YARDEN Y KUANG WJ, YANG-FENG T, COUSSENS L, MUNEMITSU S, DULL TJ, CHEN E, SCHLESSINGER J, FRANCKE U, ULLRICH A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6: 3341-3351.
6. TARN C, MERKEL E, CANUTESCU AA, SHEN W, SKOROBOGATKO Y HESLIN MJ et al. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Clin Cancer Res 2005; 11: 3668-3677.
7. BLANKE CD, EISENBERG BL, HEINRICH MC. Gastrointestinal stromal tumors. Curr Treat Options Oncol 2001; 2: 485-491.
8. STURGEON C, CHEJFEC G, ESPAT NJ. Gastrointestinal stromal tumors: a spectrum of disease Surg Oncol 2003; 12: 21-26.
9. RYAN DP, PUCHALSKI T, SUPKO JG, HARMON D, MAKI R, GARCIA-CARBONERO R, KUHLMAN C, WINKELMAN J, MERRIAM P, QUIGLEY T, JIMENO J, MANOLA J, DEMETRI GD. A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors. Oncologist 2002; 7: 531-538.
10. DEMETRI GD. Targeting the molecular pathophysiology of gastrointestinal stromal tumors with Imatinib. Mechanisms, successes, and challenges to rational drug development. Hematol Oncol Clin North Am 2002; 16: 1115-1124.
11. JOENSUU H. Gastrointestinal stromal tumor (GIST). Ann Oncol 2006; 17: 280-286.
12. SIEHL J, THIEL E. C-kit, GIST, and Imatinib. Recent Results Cancer Res 2007; 176: 145-151.
13. EISENBERG BL, JUDSON I. Surgery and Imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 2004; 11: 465-475.